Latest filing published 17 Aug 2022 for Turning Point Therapeutics, Inc., €3.1M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Mohammad Hirmand span 2 companies, the busiest being Medivation, Inc. and Turning Point Therapeutics, Inc. Over a trading history stretching from 29 September 2015 to 17 August 2022, the count stands at 20 filings.
On the market, this insider has only sold: 7 sales, €1.1M in total. Other entries cover 6 share grants and 4 option exercises. In 2022 alone, the filings show no purchases and 1 sale.
On 17 August 2022 came the latest disclosure, a transaction for €3.1M in Turning Point Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations